NO20020278L - Fosfattransportinhibitorer - Google Patents
FosfattransportinhibitorerInfo
- Publication number
- NO20020278L NO20020278L NO20020278A NO20020278A NO20020278L NO 20020278 L NO20020278 L NO 20020278L NO 20020278 A NO20020278 A NO 20020278A NO 20020278 A NO20020278 A NO 20020278A NO 20020278 L NO20020278 L NO 20020278L
- Authority
- NO
- Norway
- Prior art keywords
- fosfattransportinhibitorer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/08—Bridged systems
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14464699P | 1999-07-20 | 1999-07-20 | |
PCT/US2000/019616 WO2001005398A1 (en) | 1999-07-20 | 2000-07-19 | Phosphate transport inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20020278L true NO20020278L (en) | 2002-01-18 |
NO20020278D0 NO20020278D0 (en) | 2002-01-18 |
Family
ID=22509500
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20020278A NO20020278D0 (en) | 1999-07-20 | 2002-01-18 | Fosfattransportinhibitorer |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1202729A1 (en) |
JP (1) | JP2003504403A (en) |
KR (1) | KR20020015382A (en) |
CN (1) | CN1361687A (en) |
AR (1) | AR030911A1 (en) |
AU (1) | AU6354300A (en) |
BR (1) | BR0012568A (en) |
CA (1) | CA2379657A1 (en) |
CO (1) | CO5190714A1 (en) |
CZ (1) | CZ2002204A3 (en) |
HU (1) | HUP0202938A3 (en) |
IL (1) | IL147697A0 (en) |
MX (1) | MXPA02000753A (en) |
NO (1) | NO20020278D0 (en) |
NZ (1) | NZ516619A (en) |
PL (1) | PL353741A1 (en) |
TR (1) | TR200200112T2 (en) |
WO (1) | WO2001005398A1 (en) |
ZA (1) | ZA200200464B (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003533477A (en) * | 2000-05-12 | 2003-11-11 | スミスクライン・ビーチャム・コーポレイション | Phosphate transport inhibitors |
GB2378179A (en) * | 2001-08-03 | 2003-02-05 | Pantherix Ltd | Aromatic sulfonamides and their use in treating bacterial diseases |
AUPR738301A0 (en) * | 2001-08-30 | 2001-09-20 | Starpharma Limited | Chemotherapeutic agents |
US7119120B2 (en) * | 2001-12-26 | 2006-10-10 | Genzyme Corporation | Phosphate transport inhibitors |
US7582673B2 (en) | 2004-10-21 | 2009-09-01 | High Point Pharmaceuticals, Llc | Bissulfonamide compounds as agonists of GalR1, compositions, and methods of use |
WO2006077901A1 (en) * | 2005-01-20 | 2006-07-27 | Shionogi & Co., Ltd. | Ctgf expression inhibitor |
WO2009146875A1 (en) * | 2008-06-03 | 2009-12-10 | Fresenius Medical Care Deutschland Gmbh | Pharmaceutical compositions comprising gamma secretase modulators |
WO2018129556A1 (en) | 2017-01-09 | 2018-07-12 | Ardelyx, Inc. | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
LT2384318T (en) | 2008-12-31 | 2018-02-26 | Ardelyx, Inc. | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
US8664425B2 (en) * | 2010-02-02 | 2014-03-04 | Honeywell International Inc. | Bluegreen fluorescent compounds |
WO2012006473A1 (en) | 2010-07-07 | 2012-01-12 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
JP5823514B2 (en) | 2010-07-07 | 2015-11-25 | アーデリクス,インコーポレーテッド | Compounds and methods for inhibiting phosphate transport |
WO2012006477A1 (en) | 2010-07-07 | 2012-01-12 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
WO2012006474A2 (en) | 2010-07-07 | 2012-01-12 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
US9382239B2 (en) | 2011-11-17 | 2016-07-05 | Dana-Farber Cancer Institute, Inc. | Inhibitors of c-Jun-N-terminal kinase (JNK) |
US10376481B2 (en) | 2012-08-21 | 2019-08-13 | Ardelyx, Inc. | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
AU2013304812B2 (en) | 2012-08-21 | 2016-06-09 | Ardelyx, Inc. | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
CN103183623A (en) * | 2013-03-12 | 2013-07-03 | 中国医学科学院医药生物技术研究所 | A group of benzene sulfonamido benzamide derivatives, and preparation and application thereof |
EP3988120A1 (en) | 2013-04-12 | 2022-04-27 | Ardelyx, Inc. | Nhe3-binding compounds and methods for inhibiting phosphate transport |
CN105395532B (en) * | 2015-11-25 | 2017-11-14 | 中国医学科学院医药生物技术研究所 | Application of the 2 benzene sulfonamido benzamide compounds in liver injury protection and liver fibrosis preventing and treating |
US10793520B2 (en) | 2016-08-30 | 2020-10-06 | Nippon Soda Co., Ltd. | Sulfonylaminobenzamide compound and pest control agent |
JP7292207B2 (en) | 2017-01-09 | 2023-06-16 | アルデリックス, インコーポレイテッド | Compounds Useful for Treating Gastrointestinal Disorders |
KR20190128626A (en) | 2017-01-09 | 2019-11-18 | 알데릭스, 인코포레이티드 | Inhibitors of NHE-mediated reverse transport |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL86462A (en) * | 1987-05-29 | 1992-12-01 | Fujisawa Pharmaceutical Co | Alkanesulfonanilide derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same |
US5210079A (en) * | 1988-01-07 | 1993-05-11 | E. I. Du Pont De Nemours And Company | Treatment of chronic renal failure with imidazole angiotensin-II receptor antagonists |
-
2000
- 2000-07-18 CO CO00053928A patent/CO5190714A1/en not_active Application Discontinuation
- 2000-07-18 AR ARP000103686A patent/AR030911A1/en not_active Application Discontinuation
- 2000-07-19 NZ NZ516619A patent/NZ516619A/en unknown
- 2000-07-19 TR TR2002/00112T patent/TR200200112T2/en unknown
- 2000-07-19 PL PL00353741A patent/PL353741A1/en not_active Application Discontinuation
- 2000-07-19 CA CA002379657A patent/CA2379657A1/en not_active Abandoned
- 2000-07-19 JP JP2001510455A patent/JP2003504403A/en not_active Withdrawn
- 2000-07-19 EP EP00950437A patent/EP1202729A1/en not_active Withdrawn
- 2000-07-19 AU AU63543/00A patent/AU6354300A/en not_active Abandoned
- 2000-07-19 BR BR0012568-7A patent/BR0012568A/en not_active Application Discontinuation
- 2000-07-19 KR KR1020027000801A patent/KR20020015382A/en not_active Application Discontinuation
- 2000-07-19 CZ CZ2002204A patent/CZ2002204A3/en unknown
- 2000-07-19 IL IL14769700A patent/IL147697A0/en unknown
- 2000-07-19 CN CN00810644A patent/CN1361687A/en active Pending
- 2000-07-19 WO PCT/US2000/019616 patent/WO2001005398A1/en active IP Right Grant
- 2000-07-19 HU HU0202938A patent/HUP0202938A3/en unknown
- 2000-07-19 MX MXPA02000753A patent/MXPA02000753A/en unknown
-
2002
- 2002-01-18 ZA ZA200200464A patent/ZA200200464B/en unknown
- 2002-01-18 NO NO20020278A patent/NO20020278D0/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MXPA02000753A (en) | 2002-07-22 |
AR030911A1 (en) | 2003-09-03 |
BR0012568A (en) | 2002-04-30 |
CN1361687A (en) | 2002-07-31 |
JP2003504403A (en) | 2003-02-04 |
ZA200200464B (en) | 2003-04-30 |
CZ2002204A3 (en) | 2002-11-13 |
EP1202729A1 (en) | 2002-05-08 |
PL353741A1 (en) | 2003-12-01 |
HUP0202938A3 (en) | 2006-07-28 |
NZ516619A (en) | 2004-02-27 |
WO2001005398A1 (en) | 2001-01-25 |
KR20020015382A (en) | 2002-02-27 |
AU6354300A (en) | 2001-02-05 |
NO20020278D0 (en) | 2002-01-18 |
CO5190714A1 (en) | 2002-08-29 |
IL147697A0 (en) | 2002-08-14 |
CA2379657A1 (en) | 2001-01-25 |
HUP0202938A2 (en) | 2003-01-28 |
TR200200112T2 (en) | 2002-05-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE50010505D1 (en) | Gurtaufrollersystem | |
DE122007000064I2 (en) | Erythropoietinkonjugate | |
DE10084676T1 (en) | Einmallanzettvorrichtung | |
DE50002834D1 (en) | handstamp | |
ATE297895T1 (en) | 4-PYRIDINYL-N-ACYL-L-PHENYLALANINE | |
NO20020278L (en) | Fosfattransportinhibitorer | |
DE50015451D1 (en) | Spülwannensystem | |
DE50009570D1 (en) | Wechselcorrugator | |
DE50007953D1 (en) | Beleuchtungsanordung | |
DE50008613D1 (en) | SICHERUNGSRING | |
NO20002581D0 (en) | BÕndpassfilter | |
DE50000805D1 (en) | Aufsitzspanner | |
DE50006899D1 (en) | ANTISTATIKUM | |
DE10085008T1 (en) | Oberflächenbehandlungsdüse | |
DE50012482D1 (en) | TIBIAMARKNAGEL | |
DE60001471D1 (en) | 4-Hydroxyisothiazolverbindungen | |
DE50003660D1 (en) | DIACYLHYDRAZINDERIVATE | |
DE50006013D1 (en) | ANSCHLAGPUFFER | |
DE50003259D1 (en) | TEXTILIE | |
DE50008429D1 (en) | fuel- | |
DE50001640D1 (en) | NAHFELDOPTISCHE INTERSUCHUNGSVORRICHTUNG | |
DE50006759D1 (en) | PIPERIDINALKOHOLE | |
DE50009208D1 (en) | Hydroxyphenylvinylthiazole | |
ATE269311T1 (en) | BENZOYLPYRIDAZINE | |
DE10082008D2 (en) | Ausbeulgerät |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |